Colonial River Wealth Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Colonial River Wealth Management, LLC
- $205 Million
- Q4 2024
A detailed history of Colonial River Wealth Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Colonial River Wealth Management, LLC holds 10,094 shares of RXRX stock, worth $77,320. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,094Holding current value
$77,320% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
308Shares Held
252MCall Options Held
1.35MPut Options Held
2.32M-
Vanguard Group Inc Valley Forge, PA34MShares$261 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$248 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$190 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$133 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$118 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.38B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...